PCI Pharma Services to host London seminar on optimising the clinical trial supply chain

The free seminar event, the latest in a series from PCI’s programme of events focusing on themes around optimising clinical trial execution and commercial pharmaceutical supply, will be held on Tuesday 17 May in London, UK

Utilising traditional and innovative processes to optimise the clinical supply chain is the focus of the next PCI Pharma Services free seminar ‘Upgrading Supply Chains’. PCI is a leading provider of clinical trial supply services including drug development services, clinical trial manufacturing, packaging and labelling, as well as global storage and distribution of investigational medicines.

The free seminar event will be held on Tuesday 17 May in London'

Hosted by PCI’s Clinical Services division in partnership with World Courier and Medical Research Network, the two-hour breakfast session will provide clinical trials professionals with the opportunity to learn more about:

Investigator-initiated trials made easy: Investigator-initiated trials are a vital part of improving patient care, and the complex considerations of manufacturing and packaging investigational medical products for use in these trials include planning, feasibility assessments, flexibility for trial variables, and funding – presented by PCI’s Dr. Robbie Stewart.

Fast track packing: The handling of adaptive clinical trial designs requires maximising efficiencies and nimble and responsive supply, in order to deliver rapid packaging, labelling and distribution in clinical trials while maintaining flexibility of the drug product. The session will have a specific focus on innovations such as Fast Track and JiT and associated benefits (cost, time, compliance and quality) – presented by PCI’s Dr. Rhys Evans.

Home trial support: Innovations are being implemented in a patient-centric approach to expedite clinical development, examining the key challenges of patient recruitment and retention and the impact of patient stress, time and regulatory considerations, as well as cost considerations within the context of complex clinical trials requiring more specific patient profiles – presented by World Courier’s Dave Spillet, PCI’s Gavin Morgan, and Stuart Redding from Medical Research Network.

The seminar is the latest in a series from PCI’s programme of events focusing on themes around optimising clinical trial execution and commercial pharmaceutical supply. For more information and to register for the event, please visit: www.pciservices.com/events/london-seminar/.

Companies